Latanox

Latanoprost, the active ingredient in Latanox, is a prostaglandin analog presented as an eye drop for ocular use. It lowers intra‑ocular pressure and is prescribed for patients with open‑angle glaucoma or ocular hypertension. Latanox is supplied in a sterile ophthalmic solution suitable for once‑daily administration.

GNH USA supplies Latanox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanox belongs to the prostaglandin analog class and is used to manage conditions that involve elevated intra‑ocular pressure. - Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic nerve damage. - Ocular hypertension: lowers pressure to reduce the risk of developing glaucoma. - Secondary ocular hypertension: helps control pressure when caused by other ocular conditions.

Latanox may cause a range of ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris pigmentation: gradual darkening of eye color. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Uveitis: inflammation of the uveal tract. - Macular edema: swelling of the central retina. - Severe allergic reaction: swelling, itching, or rash. - Ocular pain: persistent discomfort. - Vision loss: sudden decrease in visual acuity. - Systemic hypersensitivity: fever, chills, or malaise.

Before prescribing Latanox, clinicians should evaluate patient history and monitor for ocular changes. - Baseline intra‑ocular pressure assessment: establish starting pressure values. - Monitor iris color changes: document any pigmentation over time. - Avoid use in active ocular infection: risk of worsening infection. - Caution in patients with a history of uveitis: may precipitate inflammation. - Do not combine with other prostaglandin analog eye drops: risk of hypotony. - Store at room temperature: keep in original container, protect from light and moisture.

Latanox can interact with other ocular or systemic agents, affecting pressure control or ocular health.

Major Interactions (Avoid): - Concurrent prostaglandin analog eye drops: additive IOP lowering may cause hypotony. - Systemic carbonic anhydrase inhibitors: may enhance pressure reduction beyond desired levels. - Ocular NSAIDs: increased risk of corneal complications.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: additive effect on IOP reduction, monitor pressure. - Topical corticosteroids: may diminish Latanox efficacy, assess response. - Systemic antihistamines: possible impact on ocular surface, observe for dryness.